Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-30

Clinical Trial Update: A Controlled Surveillance of the Osteoarthritic Knee Microenvironment With Regenexx® SD Treatment

View source ↗

Summary

The clinical trial evaluating Regenexx SD for knee osteoarthritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Regenexx SD

Snippet

Sponsor: Regenexx, LLC | Conditions: Osteoarthritis, Knee | Status: TERMINATED